Novel MSC matrix developed for diabetic wound healing

Researchers from the University of California, Davis (CA, USA) have recently designed a novel regenerative therapy to target diabetic foot ulcers (DFU) – one of the most dangerous complications of diabetes. The study has been published in Stem Cells Translational Medicine. "US healthcare expenditures for diabetes foot ulcers is over $43 billion a year. Yet, these expenditures for good standard of care – which includes such things as following a strict diet, off-loading pressure from the foot to allow wounds to heal, antibiotics or surgery – result in healing in only 30% of patients," commented Roslyn Rivkah Isseroff (UC Davis)....